Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1972 Jun;51(6):1363–1377. doi: 10.1172/JCI106932

Plasminogen-125I responses in dogs to a single injection of urokinase and typhoid vaccine and to vascular injury

Y Takeda 1
PMCID: PMC292273  PMID: 4623459

Abstract

In vivo plasminogen responses to various stimuli were studied. Plasminogen-125I was prepared and used first for metabolic studies of plasminogen in control dogs. The average results were: the plasma plasminogen, 29.3±4.1 (SD) mg/kg; the interstitial plasminogen, 8.79±4.47 (SD) mg/kg; the half-life of plasma plasminogen-125I, 2.81±0.24 (SD) days; the fractional direct catabolic rate of plasminogen (j3), 0.295 day-1; and the catabolic (synthetic) rate of plasminogen, 8.61±1.35 (SD) mg/kg per day. Studies were then made of the plasminogen-125I responses in dogs to a single injection of urokinase (A) and typhoid vaccine (B), and to vascular injury (C), which was produced by the damage of venous endothelium by a phenol injection. Effects of heparin were also studied in dogs given the phenol injection (D). Disc electrophoretic analysis of plasma showed generation of plasmin-125I in all except the control experiments. The duration of plasmin-125I generation was about 6 hr in A, 6 hr in B, and at least 5 days in C. Heparinization (D) shortened the duration of generation to about 6 hr. For further quantitative analysis of the tracer data, a model for coexistent plasminogen-125I and plasmin-125I was proposed and validated, from which some new analytical methods were derived. Using these methods, the average fractional rate of plasmin-125I generation from plasminogen-125I (j4) was 0.41 day-1 in A, 0.30 day-1 in B, 0.324 day-1 in C, and 0.382 day-1 in D. Further mathematical consideration showed that j3 was zero at least in C during plasmin generation. Plasminogen synthesis was unchanged in all experiments. The average fractional breakdown rate of plasmin-125I (j5) in A, B, C, and D was 1.19, 1.13, 1.35, and 1.11 day-1, respectively, and were closely similar. These results indicate that under normal conditions a major portion of plasminogen is directly catabolized without the formation of plasmin, but that significant amounts of plasmin were generated under the conditions described, that the normal process of direct breakdown of plasminogen is abolished during plasmin generation at least in C, and that the potential value of j5 determination should be further explored.

Full text

PDF
1363

Images in this article

1364Image
on p.1364
1366Image
on p.1366

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alkjaersig N. The purification and properties of human plasminogen. Biochem J. 1964 Oct;93(1):171–182. doi: 10.1042/bj0930171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andrews P. The gel-filtration behaviour of proteins related to their molecular weights over a wide range. Biochem J. 1965 Sep;96(3):595–606. doi: 10.1042/bj0960595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BARNHART M. I., ANDERSON G. F., BAKER W. J. Immunochemical studies on proteins important in blood coagulation. Thromb Diath Haemorrh. 1962 Oct 1;8:21–36. [PubMed] [Google Scholar]
  4. BENNHOLD H., KALLEE E. Comparative studies on the half-life of I 131-labeled albumins and nonradioactive human serum albumin in a case of analbuminemia. J Clin Invest. 1959 May;38(5):863–872. doi: 10.1172/JCI103868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BERSON S. A., YALOW R. S., SCHREIBER S. S., POST J. Tracer experiments with I131 labeled human serum albumin: distribution and degradation studies. J Clin Invest. 1953 Aug;32(8):746–768. doi: 10.1172/JCI102789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DAVIS B. J. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci. 1964 Dec 28;121:404–427. doi: 10.1111/j.1749-6632.1964.tb14213.x. [DOI] [PubMed] [Google Scholar]
  7. Deutsch D. G., Mertz E. T. Plasminogen: purification from human plasma by affinity chromatography. Science. 1970 Dec 4;170(3962):1095–1096. doi: 10.1126/science.170.3962.1095. [DOI] [PubMed] [Google Scholar]
  8. FRANKS J. J., TAKEDA Y., REEVE E. B. Preparation of autologous I-131-albumin for metabolic studies in man. J Lab Clin Med. 1962 Oct;60:619–628. [PubMed] [Google Scholar]
  9. Heberlein P. J., Barnhart M. I. Canine plasminogen: purification and a demonstration of multimolecular forms. Biochim Biophys Acta. 1968 Oct 21;168(2):195–206. doi: 10.1016/0005-2795(68)90143-8. [DOI] [PubMed] [Google Scholar]
  10. Johnson A. J., Kline D. L., Alkjaersig N. Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems, 1967-1968. Thromb Diath Haemorrh. 1969 Apr 30;21(2):259–272. [PubMed] [Google Scholar]
  11. McFARLANE A. S. The behavior of I 131-labeled plasma proteins in vivo. Ann N Y Acad Sci. 1957 Aug 30;70(1):19–25. doi: 10.1111/j.1749-6632.1957.tb35374.x. [DOI] [PubMed] [Google Scholar]
  12. McFarlane A. S. IN VIVO BEHAVIOR OF I-FIBRINOGEN. J Clin Invest. 1963 Mar;42(3):346–361. doi: 10.1172/JCI104721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. NILSSON I. M., BIELAWIEC M., BJOERKMAN S. E. THE EFFECT OF HEPARIN ON FIBRINOLYTIC ACTIVATORS AND PLASMIN. Scand J Haematol. 1964;1:75–88. doi: 10.1111/j.1600-0609.1964.tb00007.x. [DOI] [PubMed] [Google Scholar]
  14. REEVE E. B., ROBERTS J. E. The kinetics of the distribution and breakdown of 1131-albumin in the rabbit. Observations on several mathematical descriptions. J Gen Physiol. 1959 Nov;43:415–444. doi: 10.1085/jgp.43.2.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. SABISTON D. C., Jr, MARSHALL R., DUNNILL M. S., ALLISONPR Experimental pulmonary embolism: description of a method utilizing large venous thrombi. Surgery. 1962 Jul;52:9–14. [PubMed] [Google Scholar]
  16. SOLOMON A. K. The kinetics of biological processes; special problems connected with the use of tracers. Adv Biol Med Phys. 1953;3:65–97. doi: 10.1016/b978-1-4831-9926-9.50006-9. [DOI] [PubMed] [Google Scholar]
  17. TAKEDA Y. HORMONAL EFFECTS ON DISTRIBUTION AND EXCRETION OF IODIDE-I-131 IN THE DOG. Am J Physiol. 1964 Jun;206:1237–1243. doi: 10.1152/ajplegacy.1964.206.6.1237. [DOI] [PubMed] [Google Scholar]
  18. TAKEDA Y. METABOLISM AND DISTRIBUTION OF AUTOLOGOUS AND HOMOLOGOUS ALBUMIN-I-131 IN THE DOG. Am J Physiol. 1964 Jun;206:1223–1228. doi: 10.1152/ajplegacy.1964.206.6.1223. [DOI] [PubMed] [Google Scholar]
  19. TAKEDA Y., REEVE E. B. Studies of the metabolism and distribution of albumin with autologous I131-albumin in healthy men. J Lab Clin Med. 1963 Feb;61:183–202. [PubMed] [Google Scholar]
  20. TALMAGE D. W., DIXON F. J., BUKANTZ S. C., DAMMIN G. J. Antigen elimination from the blood as an early manifestation of the immune response. J Immunol. 1951 Oct;67(4):243–255. [PubMed] [Google Scholar]
  21. Takeda Y., Chen A. Y. Studies of the metabolism and distribution of fibrinogen in patients with hemophilia A. J Clin Invest. 1967 Dec;46(12):1979–1985. doi: 10.1172/JCI105687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Takeda Y. Studies of the effects of heparin, Coumadin, and vitamin K on prothrombin metabolism and distribution in calves with the use of iodine-125-prothrombin. Characterization of the prothrombin system. J Lab Clin Med. 1970 Mar;75(3):355–381. [PubMed] [Google Scholar]
  23. Takeda Y. Studies of the metabolism and distribution of fibrinogen in healthy men with autologous 125-I-labeled fibrinogen. J Clin Invest. 1966 Jan;45(1):103–111. doi: 10.1172/JCI105314. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES